Expressions of MMP-7 mRNA, sMICA, VEGF in Peripheral Blood of Lung Cancer Patients and Their Relationships with Invasion and Metastasis
-
摘要:目的
测定肺癌患者外周血中基质金属蛋白酶-7 mRNA（MMP-7 mRNA）、可溶性主要组织相容性复合体Ⅰ类相关分子A （sMICA）、血管内皮生长因子（VEGF）的表达水平，探讨它们与侵袭转移的关系及临床意义。
方法采用荧光定量反转录聚合酶链反应检测110例肺癌患者外周血中MMP-7mRNA表达含量，采用酶联免疫吸附实验检测sMICA、VEGF表达水平，并与40例健康者进行比较。
结果肺癌患者外周血中MMP-7 mRNA、sMICA、VEGF表达水平较正常对照组显著升高（P<0.05）。MMP-7 mRNA高表达含量与患者临床分期相关（P<0.05），VEGF高表达水平与病理分型、组织分化程度相关（P<0.05）。肺癌患者外周血中sMICA与MMP-7 mRNA、VEGF的表达水平呈正相关，同时MMP-7 mRNA与VEGF的表达水平呈正相关（P<0.05），治疗有效（包括手术和化疗）的肺癌患者外周血中MMP-7 mRNA、sMICA、VEGF表达水平显著降低（P<0.05），而复发转移患者的表达水平显著升高（P<0.05）。
结论MMP-7 mRNA、sMICA和VEGF共同参与了肺癌患者肿瘤转移微环境的构成，与肺癌的发生发展、侵袭转移密切相关。
-
关键词:
- 基质金属蛋白酶-7 mRNA /
- 可溶性主要组织相容性复合体Ⅰ类相关分子 /
- 血管内皮生长因子 /
- 肺癌 /
- 侵袭 /
- 转移
Abstract:ObjectiveTo test the expression levels of matrix metalloproteinases-7 mRNA(MMP-7), solubleMHC class I-related chain A(sMICA), vascular endothelial growth factor(VEGF) in the peripheral blood oflung cancer patients and determine their relationships with the invasion and metastasis and correspondingclinical significance.
MethodsThe expression of MMP-7 mRNA was determined by reverse transcriptionpolymerasechain reaction (RT-PCR) and the levels of sMICA, VEGF were measured with enzymelinked-immunosorbent assay(ELISA). Totally 110 lung cancer patients were regarded as the experimentalgroup and 40 health persons as the control group.
ResultsCompared with the control group, the levelsof MMP-7 mRNA, sMICA and VEGF in the experimental group were significantly increased (P<0.05).The overexpression of MMP-7 mRNA in lung cancer patients were related to clinical stages P<0.05),the high levels of VEGF were related to histopathological types as well as histological grades (P<0.05).The levels of sMICA had a perfect positive correlation with the levels of MMP-7 mRNA and VEGF,meanwhile, the overexpression of MMP-7 mRNA was favorably correlated to the high levels of VEGF in the peripheral blood of lung cancer patients(P<0.05); the levels of MMP-7 mRNA, sMICA and VEGF weresignificantly decreased by effective treatment including surgery and chemotherapy(P<0.05); the increasedexpressions of MMP-7 mRNA, sMICA and VEGF were found in lung cancer patients with recurrence andmetastasis(P<0.05).
ConclusionMMP-7 mRNA, sMICA and VEGF which participate in the compositionof the tumor metastasis microenvironment might have an association with occurrence, development, invasionand metastasis of lung cancer.
-
Key words:
- MMP-7 mRNA /
- sMICA /
- VEGF /
- Lung cancer /
- Invasion /
- Metastasis
-
-
![]()
图 1 肺癌患者与正常对照组外周血中MMP-7 mRNA的表达
Figure 1 Expression of MMP-7 mRNA in peripheral blood of lung cancer and healthy control groups
表 1 肺癌患者与正常对照组外周血中MMP-7 mRNA、sMICA、VEGF的表达水平
Table 1 Expression of MMP-7 mRNA,sMICA,VEGF in peripheral blood of lung cancer patients and health controls
下载: 导出CSV
表 2 肺癌患者外周血中MMP-7 mRNA、sMICA、VEGF的表达水平与临床各项指标的关系 (pg/ml)
Table 2 Relationship between expression of MMP-7 mRNA,sMICA,VEGF in peripheral blood and clinical parameters of lung cancer patients (pg/ml)
下载: 导出CSV
表 3 肺癌患者治疗前后外周血中MMP- 7 mRNA、 sMICA、VEGF表达水平的比较
Table 3 Expression of MMP-7 mRNA,sMICA,VEGF in peripheral blood of lung cancer patients before and after treatment
下载: 导出CSV
表 4 初诊时与转移后肺癌患者外周血中MMP-7 mRNA、 sMICA、VEGF表达水平的比较
Table 4 Comparison of expression of MMP-7 mRNA, sMICA,VEGF in peripheral blood of lung cancer patients between early treatment and after metastasis Items Early treatment After metastasis
下载: 导出CSV
-
[1] Wang LP, Niu H, Xia YF, et al. Prognostic significance of serum sMICA levels in non-small cell lung cancer[J]. Eur Rev Med Pharmacol Sci, 2015, 19(12): 2226-30. [1] Wang LP, Niu H, Xia YF, et al. Prognostic significance of serumsMICA levels in non-small cell lung cancer[J]. Eur Rev MedPharmacol Sci, 2015, 19(12): 2226-30.
[2] Lu H, Yang Z, Zhang H, et al. The expression and clinicalsignificance of matrix metalloproteinase 7 and tissue inhibitor ofmatrix metalloproteinases 2 in clear cell renal cell carcinoma[J].Exp Ther Med, 2013, 5(3): 890-6.
[2] Lu H, Yang Z, Zhang H, et al. The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma[J]. Exp Ther Med, 2013, 5(3): 890-6. [3] Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis[J].Cancer Metastasis Rev, 2006, 25(1): 34. [3] Deryugina EI, Quigley JP. Matrix metalloproteinases and tumormetastasis[J].Cancer Metastasis Rev, 2006, 25(1): 34.
[4] Almendro V, Ametuer E, Garcia-Recio S, et al. The role of MMP7 and its cross-talk with the FAS/FASL System during the acquisition of chemoresistance to oxaliplatin[J]. PLoS One, 2009, 4( 3): e4728. [4] Almendro V, Ametuer E, Garcia-Recio S, et al. The role ofMMP7 and its cross-talk with the FAS/FASL System during theacquisition of chemoresistance to oxaliplatin[J]. PLoS One, 2009,4(3): e4728.
[5] Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases[J]. Int J Cancer, 2006, 118(3): 684-7. [5] Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA inmalignant diseases[J]. Int J Cancer, 2006, 118(3): 684-7.
[6] EI-Gazzar A, Groh V, Spies T. Immunobiology and conflictingroles of the human NKG2D lymphocyte receptor and its ligandsin cancer[J]. J Immunol, 2013, 191(4): 1509-15.
[6] EI-Gazzar A, Groh V, Spies T. Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer[J]. J Immunol, 2013, 191(4): 1509-15. [7] Tie J, Desai J. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system[J]. Crit Rev Oncog, 20 12, 17(1): 51-67. [7] Tie J, Desai J. Antiangiogenic therapies targeting the vascularendothelia growth factor signaling system[J]. Crit Rev Oncog,2012, 17(1): 51-67.
[8] Eichmann A, Simons M. VEGF signaling inside vascularendothelial cells and beyond[J]. Cerr Opin Cell Biol, 2012, 24(2):188-93.
[8] Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond[J]. Cerr Opin Cell Biol, 2012, 24(2): 18 8-93. [9] Groh V, Wu J, Yee C, et al. Tumor-devived soluble MIC Ligandsimpair expression of NKG2D and T-cell activation[J].Nature,2002, 419(6908): 734-8.
[9] Groh V, Wu J, Yee C, et al. Tumor-devived soluble MIC Ligands impair expression of NKG2D and T-cell activation[J].Nature, 20 02, 419(6908): 734-8. [10] Zhou HJ, Qin LX. Several questions that deserve our attention in research of tumor metastatic mechanism[J]. Fudan Xue Bao(Yi Xue Ban), 2011, 38(5): 377-81. [周海军, 钦伦秀. 肿瘤转移机制 研究中几个值得关注的问题[J]. 复旦学报（医学版）, 2011, 38 (5): 377-81.] [10] 周海军, 钦伦秀. 肿瘤转移机制研究中几个值得关注的问题[J]. 复旦学报(医学版), 2011,38(5): 377-81. Zhou HJ, Qin LX. Several questions that deserve our attention inresearch of tumor metastatic mechanism[J]. Fudan Xue Bao(YiXue Ban), 2011, 38(5): 377-81.
计量
- 文章访问数: 1228
- HTML全文浏览量: 344
- PDF下载量: 342
